FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999462400> ?p ?o ?g. }

• W1999462400 endingPage "270" @default.
• W1999462400 startingPage "262" @default.
• W1999462400 abstract "The purpose of this study was to evaluate prognostic factors in patients with RCC.The expression of several biomarkers were measured by immunohistochemistry (IHC), together with 2 analytic factors (thrombocytosis and neutrophilia), in 135 patients with advanced RCC treated with new targeted drugs (NTDs) (n = 67) and/or cytokines (CKs) (n = 68)-with 23 of the patients who received CKs also receiving NTDs-between July 1996 and February 2010. Relationships with overall survival (OS) and progression-free survival (PFS) were searched for.Univariate statistical analysis revealed that high expression of hypoxia-inducible factor-1α (HIF-1α) correlated with poor prognosis in NTD treatment (PFS, 5.4 vs. 13.5, low expression months; P = .033) and CK treatment (PFS, 3.3 vs. 5.7, low expression; P = .003). Overexpression of carbonic anhydrase IX (CAIX) was associated with better prognosis with NTD treatment (OS, 32.1 vs. 7.8 months; P < .001) and CK treatment (OS, 32.9 vs. 5.9 months; P = .001). Positive PTEN was related to good prognosis with sunitinib (PFS, 15.1 vs. 6.5 months; P = .003) and CKs (OS, 13.7 vs. 7.9 months; P = .039). Increased expression of p21 was related to poor prognosis with NTD treatment (PFS, 5.9 vs. 16.8 months; P = .024) and CK treatment (PFS, 3.9 vs. 7.5 months; P < .001) Thrombocytosis was related to poor prognosis with NTDs (OS, 15.9 vs. 26.7 months; P = .007) and CKs (OS, 5.9 vs. 14.3 months; P = .010). Neutrophilia was related to poor prognosis with NTDs (OS, 17.6 vs. 25.4 months; P = .063) and CKs (OS, 5.9 vs. 12.8 months; P = .035). Multivariate analysis revealed that overexpression of CAIX was a favorable prognostic factor independent of PFS (hazard ratio [HR], 0.107; P < .001) and OS (HR, 0.055; P < .001).HIF-1α, PTEN, p21, thrombocytosis, neutrophilia, and CAIX in particular are useful prognostic factors in patients with advanced RCC." @default.
• W1999462400 created "2016-06-24" @default.
• W1999462400 creator A5024581266 @default.
• W1999462400 creator A5025411417 @default.
• W1999462400 creator A5027154797 @default.
• W1999462400 creator A5038618993 @default.
• W1999462400 creator A5041861170 @default.
• W1999462400 creator A5054197515 @default.
• W1999462400 creator A5055033732 @default.
• W1999462400 creator A5066162946 @default.
• W1999462400 creator A5074198867 @default.
• W1999462400 creator A5085476251 @default.
• W1999462400 date "2012-12-01" @default.
• W1999462400 modified "2023-09-23" @default.
• W1999462400 title "Prognostic Factors in Patients With Advanced Renal Cell Carcinoma" @default.
• W1999462400 cites W1896930635 @default.
• W1999462400 cites W1902994240 @default.
• W1999462400 cites W1970908053 @default.
• W1999462400 cites W1973112284 @default.
• W1999462400 cites W1980953738 @default.
• W1999462400 cites W1984223780 @default.
• W1999462400 cites W1989923627 @default.
• W1999462400 cites W1994643441 @default.
• W1999462400 cites W1998770945 @default.
• W1999462400 cites W2005942192 @default.
• W1999462400 cites W2010240290 @default.
• W1999462400 cites W2021256410 @default.
• W1999462400 cites W2021846579 @default.
• W1999462400 cites W2027156097 @default.
• W1999462400 cites W2031063133 @default.
• W1999462400 cites W2036900779 @default.
• W1999462400 cites W2038764684 @default.
• W1999462400 cites W2043488996 @default.
• W1999462400 cites W2047549500 @default.
• W1999462400 cites W2077889827 @default.
• W1999462400 cites W2081772067 @default.
• W1999462400 cites W2093176183 @default.
• W1999462400 cites W2123784879 @default.
• W1999462400 cites W2139806485 @default.
• W1999462400 cites W2147375714 @default.
• W1999462400 cites W2149752267 @default.
• W1999462400 cites W2150071355 @default.
• W1999462400 cites W2152575748 @default.
• W1999462400 cites W2157037524 @default.
• W1999462400 cites W2164194457 @default.
• W1999462400 cites W2167805334 @default.
• W1999462400 cites W4211144080 @default.
• W1999462400 cites W4293241248 @default.
• W1999462400 doi "https://doi.org/10.1016/j.clgc.2012.06.005" @default.
• W1999462400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22959659" @default.
• W1999462400 hasPublicationYear "2012" @default.
• W1999462400 type Work @default.
• W1999462400 sameAs 1999462400 @default.
• W1999462400 citedByCount "29" @default.
• W1999462400 countsByYear W19994624002013 @default.
• W1999462400 countsByYear W19994624002014 @default.
• W1999462400 countsByYear W19994624002015 @default.
• W1999462400 countsByYear W19994624002016 @default.
• W1999462400 countsByYear W19994624002017 @default.
• W1999462400 countsByYear W19994624002018 @default.
• W1999462400 countsByYear W19994624002019 @default.
• W1999462400 countsByYear W19994624002020 @default.
• W1999462400 countsByYear W19994624002021 @default.
• W1999462400 countsByYear W19994624002022 @default.
• W1999462400 crossrefType "journal-article" @default.
• W1999462400 hasAuthorship W1999462400A5024581266 @default.
• W1999462400 hasAuthorship W1999462400A5025411417 @default.
• W1999462400 hasAuthorship W1999462400A5027154797 @default.
• W1999462400 hasAuthorship W1999462400A5038618993 @default.
• W1999462400 hasAuthorship W1999462400A5041861170 @default.
• W1999462400 hasAuthorship W1999462400A5054197515 @default.
• W1999462400 hasAuthorship W1999462400A5055033732 @default.
• W1999462400 hasAuthorship W1999462400A5066162946 @default.
• W1999462400 hasAuthorship W1999462400A5074198867 @default.
• W1999462400 hasAuthorship W1999462400A5085476251 @default.
• W1999462400 hasConcept C126322002 @default.
• W1999462400 hasConcept C143998085 @default.
• W1999462400 hasConcept C144301174 @default.
• W1999462400 hasConcept C204232928 @default.
• W1999462400 hasConcept C2777472916 @default.
• W1999462400 hasConcept C2777802486 @default.
• W1999462400 hasConcept C2779490328 @default.
• W1999462400 hasConcept C2779788118 @default.
• W1999462400 hasConcept C2780739268 @default.
• W1999462400 hasConcept C3019894029 @default.
• W1999462400 hasConcept C38180746 @default.
• W1999462400 hasConcept C71924100 @default.
• W1999462400 hasConcept C89560881 @default.
• W1999462400 hasConcept C90924648 @default.
• W1999462400 hasConceptScore W1999462400C126322002 @default.
• W1999462400 hasConceptScore W1999462400C143998085 @default.
• W1999462400 hasConceptScore W1999462400C144301174 @default.
• W1999462400 hasConceptScore W1999462400C204232928 @default.
• W1999462400 hasConceptScore W1999462400C2777472916 @default.
• W1999462400 hasConceptScore W1999462400C2777802486 @default.
• W1999462400 hasConceptScore W1999462400C2779490328 @default.
• W1999462400 hasConceptScore W1999462400C2779788118 @default.
• W1999462400 hasConceptScore W1999462400C2780739268 @default.

• next